Biotech and Pharmaceutical
News & Jobs

Search the Site

Employers
Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

News | News By Subject | News by Disease | News By Date | Search News

Alzheimer's Disease News Articles

Get Our Industry eNewsletter FREE

email:

Top Breaking News

Failure of Baxter International, Inc.'s Trial Another Blow to Alzheimer's Treatment 5/9/2013 More...

Sanofi (France) Won't Chase Alzheimer's Therapies, Viehbacher Says 4/15/2013 More...

Former Tokai Pharmaceuticals CEO Co-Founds Startup Focused on Alzheimer's 4/5/2013 More...

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S Enter $825 Million Deal for Alzheimer's Drug 3/27/2013 More...

Orion Pharma's Alzheimer's Drug Add-On Brings Some Memory Improvement 3/12/2013 More...

After Failed Trials, Johnson & Johnson Turns to Early Stage Alzheimer's 2/13/2013 More...

Eli Lilly and Company Drug Chosen for Alzheimer's Prevention Study 1/23/2013 More...

Genentech Preps for $100 Million Alzheimer's Trial 12/19/2012 More...

Eisai Inc. Signs Neuroscience Alliance With UCL 12/13/2012 More...

Eli Lilly and Company Alzheimer’s Drug Delayed on Need for Added Study 12/13/2012 More...

Lundbeck Inc. Anticipates New Drug "Feast" 12/6/2012 More...

Bristol-Myers Squibb Company Drops Alzheimer's Drug on Little Benefit 12/5/2012 More...

Merck & Co., Inc.'s New Alzheimer's Drug Studies Offer Patients Hope 12/4/2012 More...

Johnson & Johnson Isn't Giving Up on Alzheimer Drug 11/13/2012 More...

FDA Rejects Petition to Ban Pfizer Inc. Alzheimer Pill 11/8/2012 More...

Featured Stories

Alzheimer's Markers Predict Start of Mental Decline, Washington University School of Medicine Study 5/15/2013 More...

Alzheimer's Disease is Associated With Removal of the Synaptic Protein ADAM10, University of Milan Study 5/9/2013 More...

New Perspective Needed for Role of Major Alzheimer's Gene, Washington University School of Medicine Study 5/7/2013 More...

New Light Shed on Early Stage Alzheimer's Disease, Karolinska Institute Study 4/23/2013 More...

New Genetic Markers May Signal Who is at Increased Risk for Alzheimer's Disease, Washington University School of Medicine Study 4/5/2013 More...

Feeling Hungry May Protect the Brain Against Alzheimer's Disease, University of Alabama at Birmingham Study 4/3/2013 More...

Synaptic Molecule Works Differently Than Thought; May Mean New Targets for Alzheimer's, University of California, San Diego (UCSD) Study 2/20/2013 More...

Low-Protein Diet Slows Alzheimer's in Mice, University of Southern California Study 2/15/2013 More...

Vitamin D, Omega-3 May Help Clear Amyloid Plaques Found in Alzheimer's, University of California, Los Angeles (UCLA) Study 2/7/2013 More...

Damaged Blood Vessels Loaded With Amyloid Worsen Cognitive Impairment in Alzheimer's Disease, Weill Cornell Medical College Study 2/5/2013 More...

New Drug Could Stop Alzheimer's Early in Its Tracks, Lancaster University Study 2/5/2013 More...

New Drug Might Diminish Alzheimer's Risk of Type 2 Diabetic Patients, Ben-Gurion University of the Negev Study 2/4/2013 More...

Detrimental Effect of Obesity on Lesions Associated With Alzheimer's Disease, INSERM and Universite Lille Study 1/8/2013 More...

Drug Found to Reverse Alzheimer's Memory Loss in Mice, National Institutes of Health (NIH) Study 1/4/2013 More...

Alzheimer's Linked to Brain Changes at Birth, University of North Carolina Study 1/3/2013 More...

More News

AB Science (AB.PA): Launch of a Phase 3 Clinical Trial in Alzheimer's Disease 5/20/2013 More...

Targacept, Inc. (TRGT) Completes Recruitment in Phase 2b Trial of TC-1734 in Mild to Moderate Alzheimer's Disease 4/29/2013 More...

Amarantus BioSciences, Inc. Outlines LymPro Alzheimer's Diagnostic Development Strategy 4/8/2013 More...

FDA Grants TransTech Pharma, Inc. Fast Track Designation for TTP488 for the Treatment of Alzheimer's Disease 3/19/2013 More...

Anavex Life Sciences Corp. (AVXL.OB) Comments on FDA Plan to Expedite Approval of New Alzheimer's Drugs 3/18/2013 More...

Proteome Sciences PLC (PRM.L): Developments in Alzheimer's Disease 3/18/2013 More...

Navidea Biopharmaceuticals (NEOP) Announces Completion of Additional Fundamental Clinical Trial for Radiopharmaceutical Agent, NAV4694, in Alzheimer’s Disease 1/15/2013 More...

EnVivo Pharmaceuticals, Inc. Announces Initiation of Phase 2 Clinical Trial Program of EVP-0962 in Alzheimer’s Disease 1/3/2013 More...

Kareus Therapeutics Announces Phase I Trial for Product in Alzheimer's Disease 1/3/2013 More...

Rainbow BioSciences, LLC's Pending JV Partner Amarantus Therapeutics Licenses Alzheimer's Blood Test Breakthrough 12/19/2012 More...

Biotech Support Group Release: Cyclic Nucleotide Phosphodiesterases Enrichment Product Cited in Research on Alzheimer's Disease 12/10/2012 More...

Eli Lilly and Company (LLY) Tests Med to Rid Brain Plaques In Mice With Alzheimer's 12/6/2012 More...

PRANA Biotechnology (PRAN) Completes Recruitment in Alzheimer's Trial 11/27/2012 More...

StemGenex on the Forefront of Adult Stem Cell-Based Therapy for Alzheimer's 11/14/2012 More...

EnVivo Pharmaceuticals, Inc. Presents Additional EVP-6124 Phase 2b Clinical Trial Results at the Clinical Trials on Alzheimer’s Disease (CTAD) Meeting 10/31/2012 More...